A carregar...
Evaluation of the angiotensin II receptor blocker azilsartan medoxomil in African‐American patients with hypertension
The efficacy and safety of azilsartan medoxomil (AZL‐M) were evaluated in African‐American patients with hypertension in a 6‐week, double‐blind, randomized, placebo‐controlled trial, for which the primary end point was change from baseline in 24‐hour mean systolic blood pressure (BP). There were 413...
Na minha lista:
| Publicado no: | J Clin Hypertens (Greenwich) |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8031359/ https://ncbi.nlm.nih.gov/pubmed/28493376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.12993 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|